These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24818246)

  • 1. [Routine clinical diagnosis of cognitive impairments].
    Czekaj A; Steinert T; Uhlmann C
    Psychiatr Prax; 2014 Apr; 41(3):166-7. PubMed ID: 24818246
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurocognitive enhancement therapy with vocational services: work outcomes at two-year follow-up.
    Bell MD; Zito W; Greig T; Wexler BE
    Schizophr Res; 2008 Oct; 105(1-3):18-29. PubMed ID: 18715755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MATRICS Consensus Cognitive Battery (MCCB): performance and functional correlates.
    Lystad JU; Falkum E; Mohn C; Haaland VØ; Bull H; Evensen S; Rund BR; Ueland T
    Psychiatry Res; 2014 Dec; 220(3):1094-101. PubMed ID: 25242432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theory of mind performance in schizophrenia: diagnostic, symptom, and neuropsychological correlates.
    Greig TC; Bryson GJ; Bell MD
    J Nerv Ment Dis; 2004 Jan; 192(1):12-8. PubMed ID: 14718771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurocognition, psychosocial outcome and vocational integration].
    Krüger T; Schönhoff M; Dettling M
    Psychiatr Prax; 2004 Nov; 31 Suppl 2():S224-9. PubMed ID: 15586314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons.
    Hobart MP; Goldberg R; Bartko JJ; Gold JM
    Am J Psychiatry; 1999 Dec; 156(12):1951-7. PubMed ID: 10588410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of functional improvement in a 2-year trial of cognitive enhancement therapy for early schizophrenia.
    Eack SM; Pogue-Geile MF; Greenwald DP; Hogarty SS; Keshavan MS
    Psychol Med; 2011 Jun; 41(6):1253-61. PubMed ID: 20860867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CMINDS does not have identical tests to the CATIE and MATRICS batteries. Commentary on O'Halloran et al.
    Kern RS; Green MF; Nuechterlein KH; Keefe RS
    Schizophr Res; 2009 Feb; 107(2-3):327-9; author reply 330-1. PubMed ID: 19013770
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictors of longitudinal changes in schizophrenia: the role of processing speed.
    Sánchez P; Ojeda N; Peña J; Elizagárate E; Yoller AB; Gutiérrez M; Ezcurra J
    J Clin Psychiatry; 2009 Jun; 70(6):888-96. PubMed ID: 19422757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cognitive disorders and psychosocial rehabilitation in schizophrenia].
    Llorca PM
    Encephale; 2006 Jan; 32 Pt 2():S16-7. PubMed ID: 16800082
    [No Abstract]   [Full Text] [Related]  

  • 11. [Relevance of cognitive tools for early diagnosis of schizophrenia].
    Vidailhet P
    Encephale; 2006 Oct; 32(5 Pt 4):S889-92; discussion S893. PubMed ID: 17119497
    [No Abstract]   [Full Text] [Related]  

  • 12. Internal consistency, temporal stability and neuropsychological correlates of three cognitive components of the Positive and Negative Syndrome Scale (PANSS).
    Bryson G; Bell M; Greig T; Kaplan E
    Schizophr Res; 1999 Jul; 38(1):27-35. PubMed ID: 10427608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive mechanisms, psychosocial functioning, and neurocognitive rehabilitation in schizophrenia.
    Penadés R; Boget T; Catalán R; Bernardo M; Gastó C; Salamero M
    Schizophr Res; 2003 Oct; 63(3):219-27. PubMed ID: 12957701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rehab rounds: cognitive modifiability as a measure of readiness for rehabilitation.
    Wiedl KH
    Psychiatr Serv; 1999 Nov; 50(11):1411-3, 1419. PubMed ID: 10543848
    [No Abstract]   [Full Text] [Related]  

  • 16. [Neuropsychology in occupational rehabilitation: a new field of intervention?].
    Müller SV; Klaue U; Specht A; Schulz P
    Rehabilitation (Stuttg); 2007 Apr; 46(2):93-101. PubMed ID: 17464904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to the appropriate clinical use of medications that improve the cognitive deficits of schizophrenia.
    Bromley E
    Psychiatr Serv; 2007 Apr; 58(4):475-81. PubMed ID: 17412848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of cognitive problems in schizophrenia and implications for vocational functioning.
    Tan BL
    Aust Occup Ther J; 2009 Aug; 56(4):220-8. PubMed ID: 20854522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social cognitive markers of short-term clinical outcome in first-episode psychosis.
    Montreuil T; Bodnar M; Bertrand MC; Malla AK; Joober R; Lepage M
    Clin Schizophr Relat Psychoses; 2010 Jul; 4(2):105-14. PubMed ID: 20643633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and cognitive factors affecting psychosocial functioning in remitted patients with bipolar disorder.
    Konstantakopoulos G; Ioannidi N; Typaldou M; Sakkas D; Oulis P
    Psychiatriki; 2016; 27(3):182-191. PubMed ID: 27837572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.